MSH3 is associated with the development of various cancers (30), and some studies have shown that MSH3 is associated with the development of primary nasopharyngeal (31), prostate cancer (32), esophageal cancer (33), colorectal cancer (34), breast cancer (35), while studies on renal cell carcinoma are rare. Here, MSH3 is linked to breast cancer.